Donnerstag USA Veröffentlichungen u.a. Alexion Pharmaceuticals und Baker Hughes

Am 28. Juli veröffentlichen diesen Amerikanische Unternehmen ihre Geschäftsergebnisse.

  • A10 Networks
  • ACI Worldwide
  • ACNB
  • Acorda Therapeutics
  • Affinion Groups
  • Aflac
  • Air Products and Chemicals
  • Alexion Pharmaceuticals
  • Align Technology
  • AllianceBernstein LP
  • Almost Family
  • Alphabet
  • Ameresco
  • American Vanguard
  • Amerisafe
  • Amgen
  • Ampco-Pittsburgh
  • Apartment Investment and Management
  • Applied Micro Circuits
  • Aptargroup
  • Aresmmercial Real Estate
  • Armstrong World Industries
  • Atlas Air Worldwides
  • ADP
  • AV Homes
  • Avon Products
  • AXT
  • Baker Hughes
  • Ball Corp
  • Bay Bancorp
  • Bay Banks of Virginia
  • Bear State Financial
  • Bemismpany
  • Blucora
  • BofI
  • BorgWarner
  • Boston Beer
  • Brightcove
  • Brinks
  • Bristol-Myers Squibb
  • Broadwind Energy
  • Brunswick
  • Bunge
  • Cabot Microelectronics
  • CalAtlantic Group
  • Callidus Software AG
  • CARBO Ceramics
  • Cardtronics
  • Carolina Banks
  • Carpenter Technology
  • Cash America International
  • CBL & Associates Properties
  • CBS Corp.
  • Cemtrex
  • CEVA
  • Charles River Laboratories International
  • Chart Industries
  • Chefs Warehouse
  • Chemtura
  • Cheniere Energy
  • Cheniere Energy Partners LP
  • Cheniere Energy Partners LPs LLC
  • Chesapeake Lodging Trust
  • Ciber
  • Cigna
  • Citizensmmunity Bank
  • Clear Channel Outdoors
  • CME Group Inc.
  • CMS Energy
  • Coherent
  • Cohu
  • Colfax
  • Colgate-Palmolive
  • Columbia Property Trust
  • Columbia Sportswear
  • Comfort Systems USA
  • Commonwealth Business Bank
  • Community Bankers Trust
  • CommunityOne Bancorp
  • Computer Programs and Systems
  • ConocoPhillips
  • Control4
  • Cowen Group
  • CPS Technologies
  • CRA International
  • Cray
  • Crocs
  • Cumulus Media
  • CVR Energy
  • CVR Partners LP
  • CVR Refining LP
  • Cytokinetics

    Zusammengestellt von Redaktion Valuefokus und Citigate First Financial.